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Abstract
The ability to image platelets in vivo can provide insight into blood clotting processes and
coagulopathies, and aid in identifying sites of vascular endothelial damage related to trauma or
cardiovascular disease. Toward this end, we have developed a magnetomotive ultrasound
(MMUS) system that provides contrast-enhanced imaging of superparamagnetic iron oxide (SPIO)
labeled platelets via magnetically-induced vibration. Platelets are a promising platform for
functional imaging contrast because they readily take up SPIOs and are easily harvested from
blood. Here we report a novel MMUS system that accommodates an arbitrarily thick sample while
maintaining portability. We employed a frequency- and phase-locked motion detection algorithm
based on bandpass filtering of the differential RF phase, which allows for the detection of sub-
resolution vibration amplitudes on the order of several nanometers. We then demonstrated MMUS
in homogenous tissue phantoms at SPIO concentrations as low as 0.09 mg/ml Fe (p < 0.0001, n =
6, t-test). Finally, we showed that our system is capable of 3-dimensional imaging of a 185 μL
simulated clot containing SPIO-platelets. This highlights the potential utility for non-invasive
imaging of platelet-rich clots, which would constitute a fundamental advance in technology for the
study of hemostasis and detection of clinically relevant thrombi.
1. Introduction
Platelets play an important role in the processes of hemostasis and thrombosis, which are
closely linked to many blood diseases and conditions (Jurk and Kehrel 2005). The
pathophysiological function of platelets is to actively respond to endothelial damage by
forming a platelet-rich thrombus that inhibits blood flow (primary and secondary
hemostasis), where the type of endothelial disruption dictates the clinical relevance of the
thrombus. For example, occlusive thrombus formation often results from the rupture of a
vulnerable atherosclerotic plaque, and is the leading cause of myocardial infarction and
stroke. Importantly, pre-occlusive thrombosis complicating atherosclerosis, if properly
diagnosed, may be attended to before becoming occlusive (Lloyd-Jones et al 2010).
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Alternatively, non-pathogenic hemostasis involves the formation of platelet-rich thrombi
that halt internal hemorrhage (Becker 2008). Thus, platelet-rich thrombus formation is
broadly relevant for diagnosing and studying cardiovascular disease (CVD) and trauma.
Imaging technologies for detecting and longitudinally monitoring the development of
platelet-rich thrombi would therefore greatly aid in the study and diagnosis of CVD and
internal hemorrhage. In this paper, we address this need by a first demonstration of a non-
invasive and portable magnetomotive ultrasound (MMUS) technique capable of contrasting
platelet-rich clots formed from SPIO-labeled platelets.
The current clinical standard for detecting platelet-rich thrombi is X-ray angiography, and
emerging imaging strategies are being developed using MRI, CT, and PET (Ciesienski and
Caravan 2010, Sanz and Fayad 2008). Though these imaging modalities are helpful in
diagnosing blood related diseases, ultrasonic imaging offers lower cost, portability, and
avoids the radiation hazard associated with X-rays. Micrometer and submicrometer-sized
bubbles have been extensively employed in ultrasonic imaging to provide molecularly-
sensitive imaging to a wide variety of pathologies (Kaufman and Linder 2007, Ferrara et al
2007). Also, ultrasound radiation force methods have been developed to provide image-
guided drug delivery via microbubble carriers (Lum et al 2006, Patil et al 2009, Patil et al
2011). There are also emerging methods for molecular imaging with photoacoustic
tomography using nanoparticles (Zerda et al 2010, Li et al 2008). Each of these techniques
offers advantages and disadvantages in comparison to the proposed use of SPIO-labeled
platelets. First, microbubbles provide bright field contrast, which enhances sensitivity to
small vessels; in comparison, photoacoustic and magnetomotive contrast methods are
darkfield, providing specific imaging of molecular imaging agents that can be overlaid onto
the brightfield image. Second, traditional molecular imaging methods rely upon receptor-
ligand binding of micro- and nanoparticles; in comparison, platelets are activatable and
respond to their environment, presenting multiple types of tethering structures and changing
shape to facilitate adhesion to sites of inflamed and damaged vascular endothelium (Jurk and
Kehrel 2005).
At the same time, the recent development of novel imaging technologies like high speed
confocal and wide-field microscopy (Falati et al 2002), intravital video microscopy (Furie
and Furie 2005, Nishimura et al 2012), and nanoscale spectral CT molecular imaging (Pan
et al 2010) provide high-resolution imaging of thrombus formation in small animals,
including longitudinal information on thrombus composition and physical structure. While
these techniques have contributed significantly to our understanding of thrombosis and
hemostasis, they are invasive and impractical for in vivo imaging in humans. Imaging
technologies with the ability to noninvasively locate platelets in an in vivo environment
could be employed both as a research imaging tool in large animal models, and provide
biomedical imaging in humans for detection of internal vascular damage and clinically silent
or pre-occlusive thrombosis.
Platelets have been shown to readily take up nanoparticles via immune processes (White et
al 1999) and when labeled with imaging contrast agents, provide a platform for functional
imaging. Since the 1970s, platelets have been used as radio labeled contrast agents in
gamma ray imaging for the study of blood related diseases (Fuster et al 1979). In recent
work, we showed that platelets exhibit an affinity for the uptake of superparamagnetic iron
oxide (SPIO) contrast agents, enabling imaging by magnetomotive optical coherence
tomography (MMOCT) (Oldenburg et al 2010, Oldenburg et al 2012).
Magnetomotive imaging is a method for contrasting magnetically labeled agents that are
non-echogenic by detecting the motion of echogenic materials to which they are
mechanically coupled in response to an applied magnetic field (in otherwise non-magnetic
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tissue), which was first demonstrated using OCT (Oldenburg et al 2005), and later
demonstrated in ultrasound (Oh et al 2006). The amplitude of the magnetomotion depends
upon the particle distribution, particle magnetization, magnetic field strength and gradient,
and the mechanical properties of the surrounding medium (Oldenburg et al 2005a). Given
that OCT offers limited penetration depth (~1–2 mm), and that OCT and ultrasound are both
reflection-based, interferometric imaging techniques, this manuscript represents the
translation of our phase-sensitive techniques for magnetomotive imaging of SPIO-platelets
to an ultrasound platform. This extends the imaging penetration depth by over an order of
magnitude, broadening the potential application base to include non-invasive, in vivo
imaging of peripheral vasculature (within ~2–3 cm of the surface).
Magnetomotive ultrasound (MMUS) was first demonstrated using standard Doppler
techniques for detection of SPIO uptake in ex vivo mouse liver (Oh et al 2006). Doppler-
based MMUS was further developed to image uptake in live macrophages embedded in agar
(Mehrmohammadi et al 2007). Advances toward more robust MMUS motion detection
algorithms were developed to enhance the signal-to-noise ratio (SNR) (Holst et al 2010) and
efforts toward quantitative MMUS have been made (Evertsson et al 2011). Furthermore,
different methods of magnetic field delivery and SPIO optimization have been explored
(Mehrmohammadi et al 2011, Mehrmohammadi et al 2011a, Mehrmohammadi et al 2011b).
The coupling of MMUS with photo-acoustic tomography using dual-function nanoparticles
has also been demonstrated (Qu et al 2011).
Here we report further advances in MMUS technology toward clinical application and
functional imaging of platelets. We have designed a novel magnetic field delivery system
that allows for open air imaging of arbitrarily thick samples, which is readily translatable to
large animal and human studies. The MMUS signal is extracted with high sensitivity and
specificity using a frequency- and phase-locked method translated from our previous work
in MMOCT (Oldenburg et al 2008), and similar to other MMUS work by Holst et al (2010).
The method presented here provides several advantages: 1) It rejects noise outside the
frequency passband (frequency-locking), 2), it rejects background motion that is out-of-
phase with the driving force (phase-locking), and 3) it further suppresses low-frequency
noise (such as 1/f noise) by use of the differential phase. With this novel MMUS system we
show that we can detect motion in homogenous tissue phantoms and in small platelet-rich
clot-like inclusions at physiologically feasible concentrations. This lays a foundation for
translation to in vivo experiments that can provide fundamental knowledge about hemostasis
arising from trauma and thrombosis.
2. Materials and Methods
2.1. Open-Air MMUS System Setup
The open-air MMUS system (Figure 1) is comprised of an UltraSonix SonixTouch Research
machine with a L14-5/38 linear array transducer operating at a center frequency of 10 MHz.
The ultrasound transducer is mounted between a pair of custom, water-jacketed solenoid
electromagnets that provide a temporally modulated magnetic field gradient during imaging.
An arbitrary waveform generator signals two identical power supplies (Kepco model
ATE-75-15M, 1000 Watt), which power the two electromagnets to produce the magnetic
field. The ultrasound system triggers the waveform generator so that the electromagnets
begin generating a field at the same instance the system begins collecting ultrasound data.
This triggering allows us to phase filter mechanical noise from the MMUS signal. The
electromagnets have cores made from laminated layers of grain-oriented electrical steel
(ATI Allegheny Ludlum), and are in a solenoid configuration composed of 20 gauge magnet
wire wound with inner and outer radii of 3.5 cm and 6.8 cm, respectively, and a height of
10.7 cm. To produce a maximum gradient force they are operated in an anti-parallel
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configuration and positioned directly above the tissue phantoms at a tilt angle of 25 degrees.
The coil dimensions, wire gauge, and tilt angle were chosen using a multi-dimensional
optimization algorithm to model and maximize the resulting magnetic gradient force within
the imaging area. The imaging apparatus is mounted on a vibrattion isolation table to reduce
ambient mechanical noise. The sample and transducer holders are also mechanically
decoupled from the electromagnets to avoid detection of mechanical vibrations of the
electromagnets. At the same time, the transducer and electromagnets are co-mounted on a 1-
d axial (z) translation stage to enable positioning of the transducer onto the sample while
maintaining alignment of the electromagnets in the B-mode (x-z) plane. The sample holder
is mounted on a 1-d elevational (y) translation stage to allow for 3-d MMUS imaging.
2.2. Data Collection and Analysis
Each MMUS data set consisted of two 8-second sets of ultrasound data (2-d B-mode style
RF acquisition) acquired using “RF mode” on the SonixTouch for off-line processing
(61.667 frames per second). One set was taken while the B-field was modulated at 2.0031
Hz (the frequency of which was chosen to ensure proper operation of Goertzel algorithm
described below) and one set taken with the B-field completely off. The field-off data allows
for subtraction of ambient noise during processing. For 3-d imaging, the sample was
translated in elevation while the transducer and magnets maintained fixed positions.
We then employed a slow time phase-sensitive motion detection algorithm. It is similar to
that previously used in magnetomotive OCT (Oldenburg et al 2008), and similar to a
recently reported frequency- and phase-locked method for MMUS (Holst et al 2010) with
the exception that our method employs slow time differential phase to suppress 1/f noise.
First, we write the time-varying magnetic gradient force as:
where ωmagnet is the magnetic oscillation frequency, t is the time elapsed since the magnet
was switched on, and φmagnet is the phase of the magnetic oscillation at t=0. Once it has
reached a steady-state, the magnetically-induced axial (z) displacement of the tissue can be
written as:
where A is the vibration amplitude and  corresponds to the position of each pixel in the
image. The size of A is proportional to the SPIO loading and tissue compliance (Oldenburg
et al 2008). Finally, the magnetically-induced acoustic phase shift will be:
where c is the speed of sound in tissue, and f is the acoustic frequency. Here we assume that
c is constant, although a more accurate estimation can be made by accounting for its depth-
dependence (Loupas et al 1995). We expect this effect to induce <5% error in the
measurements reported in this study.
Ultimately, A represents the SPIO-induced signal that we wish to extract from the acoustic
measurements. To accomplish this, we first acquired beamformed RF data as above, and in
postprocessing, we computed the Hilbert transform of the entire 8 second data set in slow
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time to extract the complex analytic ultrasound signal. The phase (argument) of this
complex analytic signal is the measured acoustic phase, which can be written as:
where N represents a noise term. We then computed the differential phase from successive
time samples:
which can then be written in terms of our magnetically induced signal and noise as:
For convenience we will neglect the constant terms in front of A. We then acquire the
temporal Fourier transform of the differential phase which becomes:
where δ is the Dirac delta function. The amplitude of this Fourier spectrum for
representative data is shown in Figure 2.
In order to filter the signal at the magnet oscillation frequency, the Goertzel algorithm was
used as it is a computationally efficient method for computing a single Fourier component
from a discrete Fourier transform (Proakis and Manolakis 1996). This was applied to each 8
second data set to extract the Fourier component of the differential phase at ωmagnet. This
Fourier component can then be written as  as follows:
where we write expressions for the signals obtained with the magnetic field on and off,
indicated as subscripts Bon and Boff, respectively. We then apply a cosine phase filter of the
following form:
This selects the motion in phase with the oscillating magnetic field (Oldenburg et al 2008).
For the case of more viscous samples (causing an additional phase lag) the reference phase
term, φmagnet, may be modified to maximize detection of the desired motion. Finally, for
rendering of MMUS contrast images we then display the value of
. To generate an image-averaged measure of the
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magnetomotive signal, the signal-to-noise ratio (SNR) was computed from the ratio
( ). For SPIO inclusions, the SNR was calculated for a manually
selected region isolating the inclusion. As shown in Supplemental Material, with this slow
time frequency- and phase-sensitive method we can detect sub-resolution motion on the
order of a few nanometers.
2.3. Magnetic Field and Force Characterization
To obtain the largest possible SNR in MMUS it is necessary to maximize the z-component
of the magnetic gradient force, Fz, produced by the electromagnets. To characterize this
force, we measured the horizontal (x) and vertical (z) components of the magnetic field
produced by the electromagnets within the imaging area of interest using an FW Bell 5180
Gauss/Tesla meter with an STD18-0404 probe that has a 0.38 mm diameter active sensor
area. According to the following equation: Fz ∝ Bx (dBx / dz) + By (dBy / dz) + Bz (dBz / dz),
we computed a map proportional to the z component of force on SPIOs in the tissue
phantom (see Figure 4(g)). (Note that the magnitude of the force depends upon the field-
dependent volume magnetization  of the SPIOs according to , where
 is the dipole moment of the particles given by , and V is particle volume). After
testing the magnets in both parallel and anti-parallel configurations it was found that anti-
parallel polarizations produced the maximum force within the imaging area. It is interesting
to note that, for the anti-parallel configuration, the predominant contribution to Fz is from
the Bx (dBx / dz) (transverse) term. Correspondingly, all MMUS data was collected with the
magnets in the anti-parallel configuration with an average field of 0.05 T and gradient of
0.09 T/m within the imaging area. While our electromagnets were designed to accommodate
up to a 5 cm depth to match that of our ultrasound system, different electromagnet designs
could be employed to deliver magnetic field gradients to larger depths.
2.4. SPIO-Labeled Platelet Preparation
Platelets were harvested from fresh blood drawn in anticoagulant citrate dextrose solution
from 3-year-old normal female pigs at the Francis Owen Blood Research Laboratory
according to approved protocols of the Institutional Animal Care and Use Committee at the
University of North Carolina at Chapel Hill. We followed a modified version of a protocol
developed by Aurich et al (2012). First, whole blood was centrifuged (100 g, room
temperature, 20 min) to separate platelet rich plasma (PRP). The platelet concentration of
PRP was determined by cell counter (SCIL Vet animal blood counter calibrated for pig
cells) and 2 ml of red blood cells were set aside for later use in platelet rich clot formation.
Platelets were then pelleted by spinning in a fixed-angle centrifuge at 800 g for 8 minutes.
The platelet poor plasma (PPP) was decanted from the pellets and stored on ice for later use.
For SPIO labeling, platelet pellets were resuspended in citrated saline (CS) to form a stock
platelet solution and then further diluted with CS to a final concentration of 50×106
platelets/ml and either 0.5 mg Fe/ml SPIOs (Ocean Nanotech 10 nm, SHP 10-50) or no
SPIOs as a control. These were incubated at 37°C for 1 hr 20 min. (At this point, samples
were taken for visual evaluation of uptake by Transmission Electron Microscopy (TEM):
400 μL of SPIO-platelets and control platelets were fixed in 1% gluteraldehyde for 30
minutes and pelleted at 400 g for 15 minutes, then overlaid with 2% gluteraldehyde and
taken to Microscopy Services Laboratory-UNC School of Medicine.) SPIO-platelets were
then pelleted (800 g, room temperature, fixed angle, 8 minutes) and supernatant containing
free SPIOs was removed. It was verified that a control solution with only SPIOs exhibited
no pelleting under these conditions. SPIO-platelets were re-suspended with 1 ml of CS for
further analysis and phantom preparation. 100 μl of both platelet solutions were then
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analyzed for Fe content by mass spectrometry (ICPMS, Mass Spectroscopy Facility, UNC
Department of Chemistry).
2.5. Phantom Preparation
We employed homogeneous tissue phantoms to determine the SPIO concentration-
dependence of MMUS, and phantoms with an inclusion to study the spatial response of our
system. See supplemental materials for detailed phantom preparation methods.
3. Results and Discussion
3.1. SPIO Uptake in Platelets
TEM imaging of an SPIO-labeled platelet, (Figure 3), reveals the presence of hundreds of
SPIOs within the surface-connected open canalicular system of the platelet. SPIO uptake in
platelets was quantified by mass spectrometry. It was found that each of the labeled platelets
contains, on average, 140 fg of Fe, which is comparable to our previously reported efforts
under varying conditions (Table 1), although somewhat smaller than that reported by Aurich
et al (2012). Further investigation is needed to understand how the differences in SPIO size,
SPIO coating, incubation concentrations, platelet source, and platelet/SPIO separation
methods relate to differences in platelet iron uptake.
3.2. MMUS of Homogeneous Tissue Phantoms
Figure 4 shows representative US and MMUS images of a 0.3 mg Fe/ml phantom in
comparison to control. We found that MMUS contrast is only apparent in the SPIO phantom
in the presence of a modulating magnetic field. There is some inhomogeneity in the MMUS
image that may be explained by inhomogeneities of the magnetic field and field gradient in
the imaging area of interest. As shown in panels b) and g) of Figure 4, the MMUS signal
pattern is strongly correlated with that of the force field. The force is somewhat concentrated
near the axes of the electromagnet cores, while slightly stronger forces observed on the left
side of the images may be attributed to slight inconsistencies between our two custom-made
electromagnets. Horizontal lines near the bottom of the images are caused by acoustic
interference patterns due to back reflection from the bottom of the phantom molds.
MMUS was performed on homogeneous phantoms of varying SPIO concentration. Data
displayed in Figure 5 demonstrates that the SNR of our MMUS system monotonically
increases over SPIO concentrations ranging from 0.091 mg Fe/ml to 0.91 mg Fe/ml. Each
data point in Figure 5 represents the mean and standard deviation of SNR for 6 MMUS
images (3 different locations, 2 acquisitions at each location). From this data, we see that the
system can detect magnetically induced motion at a concentration of .091 mg Fe/ml in
comparison to control (p < 0.0001, n = 6, t-test). In comparison, with closed MMUS systems
Evertsson et al (2013) report a vibration amplitude sensitivity to 0.45 mg Fe/ml, and
Mehrmohammadi et al (2007) show magnetomotive signal at concentrations of 0.07 mg Fe/
ml.
In our experiments, non-random motion (SNR ~0.7 dB) was observed in control phantoms
that did not contain SPIOs. It is suspected that these motions arise from mechanical
vibrations of the electromagnet cores that translate through the table to the graphite control
samples. This hypothesis is consistent with the observation that the MMUS images of the
graphite control phantoms exhibit an evenly distributed pattern that does not correspond to
the magnetic gradient force map, unlike the MMUS signal in SPIO phantoms.
As another comparison, past MMOCT studies exhibited a sensitivity to SPIO laden platelets
with final Fe content between .060 and .070 mg Fe/ml (p < 0.0001, n = 9, t-test) (Oldenburg
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et al 2010) and 0.027 mg Fe/ml in homogeneous tissue phantoms (Oldenburg et al 2008).
Interestingly, for MMOCT, sensitivity is ultimately limited by diamagnetically-induced
motion of the water in the sample. This occurs when fields above the magnetic saturation
point of SPIOs are used, which is a regime where diamagnetic motion increases nonlinearly
while SPIO motion increases only linearly with increasing magnetic field (Oldenburg et al
2010). With this in mind, our open air magnetic field delivery system was designed to
operate with field strengths below the saturation field of the SPIOs (0.1 – 0.2 Tesla).
Consistent with this picture, we find no evidence that diamagnetic motion is significant in
the open air MMUS.
To explore the vibration amplitude sensitivity we analyzed the motion of the lowest
concentration sample and determined a nominal 3 dB sensitivity to harmonic vibrations on
the order of 5 nm. A detailed explanation of this analysis may be found in the supplemental
materials. It is important to note that this vibration amplitude sensitivity is not equivalent to
the true displacement sensitivity of the system, because a priori knowledge of the vibration
waveform is used to extract the amplitude. Using data analysis techniques similar to ours,
Evertsson et al (2013) report vibrations within phantoms on the order of 50 nm. Notably, in
their work on harmonic motion detection in vibrating media using ultrasound, Urban et al
(2008) report vibration amplitude sensitivity as low as 100 nm. Toward the goal of in vivo
studies and clinical translation, we are encouraged that the vibration amplitude sensitivity of
this open air MMUS system compares favorably to existing methods of harmonic motion
detection.
3.3. MMUS of Phantoms with Agar Inclusions and Platelet Rich Clots
To illustrate the potential of MMUS as a clinical tool for thrombus detection, we performed
imaging of phantoms containing both SPIO-laden agar inclusions and SPIO-labeled platelet
rich clots. The SPIO agar inclusion consisted of 1000 μl of .91 mg Fe and agar mixture,
embedded ~10 mm beneath the phantom surface (Figure 6) while the SPIO-labeled platelet
rich clot had a volume of 185 μl with an iron concentration of 4.7 mg Fe/ml (or 140 fg Fe/
platelet). All together, the data shows that MMUS provides specific contrast only at the
known positions of the SPIO-laden inclusions, including those comprised of SPIO agar and
SPIO-labeled platelets in clots. In parts a) and b) of Figure 6, it can be clearly seen that in
planes where neither inclusion exists (plane 1 the magnetomotive contrast is virtually non-
existent. Conversely, the MMUS image plane located through the inclusion (plane 4)
exhibits magnetomotive contrast only in the phantom with SPIOs in the inclusion, and is
concentrated in the center of the image, corresponding to the known location of the
inclusion.
Furthermore, in parts c) and d) we compare elevationally-scanned MMUS images of the
agar inclusions to that of the platelet-rich clot inclusions. The iron concentration of the SPIO
agar inclusion was 0.91 mg Fe/ml while the iron concentration of the SPIO-labeled platelet
rich clot was 4.7 mg Fe/ml. This may account for the accordingly larger SNR observed for
the SPIO-labeled platelet rich clot (6.35 dB) in comparison to the SPIO agar inclusion (1.27
dB). SNR may also depend upon batch variability in the magnetization of SPIOs, and
differences in the visco-elastic properties of the clots versus agar.
3.4. Discussion and Future Outlook
These results demonstrate that MMUS can locate SPIO-labeled platelets incorporated into
clots within 3D tissue phantom volumes. Considering translation of this technology, in vivo
platelet-rich thrombi can be comprised of a very high concentration of platelets. One study
estimated that platelets comprise between 35–70% of thrombus by area (Sato et al 2005),
corresponding to a concentration similar to that used in this study. The ability for MMUS to
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detect thrombosis in vivo will depend upon the fraction of platelets incorporated into the
thrombus that are SPIO-labeled, the SPIO loading per platelet, and the total volume of the
thrombus. Further development of SPIO-labeled platelets is also likely to improve existing
loading efficiencies by gaining a better understanding of the effects of particle size, coating,
and incubation conditions. The use of rehydratable, lyophilized (RL) platelets may also
enable efficient harvesting, preparation, and storage of SPIO-RL platelets for MMUS
imaging (Read et al 1995).
The image processing algorithm presented in this paper describes a phase- and frequency-
locked method that operates in slow-time upon the differential acoustic phase. This method
rejects noise lying outside a very narrow passband, and further rejects noise that is out of
phase with the driving magnetic field. This may be particularly robust when translating to in
vivo imaging environments exhibiting other cyclical motions due to cardiopulmonary
function. It will also reject non-harmonic motion, such as from SPIO-platelets that are not
elastically bound, but are free within the blood volume. MMUS sensitivity may further
benefit from the optimization of magnetic modulation frequency, which has begun to be
addressed by Evertsson et al (2011). While higher frequencies would enable faster imaging
rates, these will need to be balanced against possible tissue viscoelastic effects that damp
vibrations, and the available frame rate and noise spectrum of the ultrasound hardware.
Also, the choice of the optimum magnetic modulation frequency will depend strongly upon
the in vivo noise spectrum from the aforementioned physiological motion artifacts. For this
reason, we believe the next crucial step will be validating MMUS in an in vivo environment
to more rapidly address challenges blocking the path to translation.
4. Conclusion
In summary, we have demonstrated a novel open-air MMUS system that enables contrast-
enhanced imaging of SPIO-labeled platelet rich clots embedded in 3-D tissue phantoms.
Both the vibration amplitude sensitivity and SPIO concentration sensitivity of this MMUS
system compare favorably with other closed MMUS systems, while additionally being
capable of accommodating arbitrarily large samples for translational imaging. This poises
the technology for translation to in vivo animal imaging studies which will present new
challenges for the technological advancement of MMUS. This research constitutes a first
step toward contrast-enhanced imaging of SPIO-labeled platelets to study the mechanisms of
thrombosis and to provide a sensitive clinical diagnostic for pre-occlusive thrombosis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Caartoon diagram of the open-air magnetomotive ultrasound (MMUS) system. The green
inset illustrates the acoustic phase shift arising from magnetomotion in the sample, where Δz
is tissue displacement, c is speed of sound in tissue, and f is acoustic frequency
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Example of data processing applied to a single pixel for detection of magnetically induced
motion at 2 Hz in a homogeneous SPIO phantom. a) and b) show plots of the differential
phase versus time. c) and d) illustrate the amplitudes from the corresponding Fourier
transforms of the differential phase plots. Note that the 2 Hz peak only appears when the B-
field is modulated. The second harmonic at 4 Hz is expected due to the square-law
dependence of magnetic gradient force with the magnet current, although harmonics may
also arise from other nonlinearities such as viscoelasticity.
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Transmission Electron Micrograph of an SPIO-labeled platelet. White arrows indicate areas
of SPIO uptake while black arrows distinguish glycogen. Magnified inset shows the uptake
individual SPIOs.
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Imaging of homogeneous tissue phantoms (top row: 0.3 mg Fe/mL SPIO phantom, bottom
row: control). a) and d) Representative ultrasound images. b) and e) MMUS images
(represented by parameter Sfilt calculated as described in section 2.2) obtained with the
magnetic field modulated at 2 Hz, and c) and f) corresponding MMUS images with the
magnetic field off. White corresponds to areas of maximum acoustic phase shift while black
corresponds to no motion. g) Map of the z-component of the magnetic gradient force within
the US imaging area. As expected, the force field pattern matches that of the magnetomotive
displacement observed in the SPIO field-on image of panel b.
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MMUS SNR vs. SPIO concentration in homogenous tissue phantoms.
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B-mode ultrasound and corresponding MMUS SNR images of graphite agar phantoms
embedded with a graphite (control) inclusion, an SPIO-laden inclusion, a platelet (control)
clot, or an SPIO-labeled platelet clot, as indicated. a) Images for plane 1 (transducer not over
inclusion). b) Images for plane 4 (transducer over inclusion). c) & d) Projections of MMUS
images (averaged in z) arising from elevational scans stepped in x. c) Elevational scans of
inclusions corresponding to the phantoms from a) and b). d) Elevational scans of platelet
rich clots (left = control clot, right = SPIO-labeled platelet clot). We observe a strong
correspondence of MMUS contrast to the known SPIO inclusion and clot positions in both
the y-z and x-y planes.
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Table 1
Summary of platelet SPIO uptake experiments.





Dextran 30-40 Human Size exclusion chromatography 43
Oldenburg et al
2011
Dextran 30-40 Human Centrifugation 217
Aurich et al 2012 Carboxy-dextran 45-60 Human Centrifugation 2000
This work CO-OH 18-20 Porcine Centrifugation 140
a
Separation of platelets from excess SPIOs
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